Related Experiment Video
Updated: Jan 13, 2026
Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty
Published on: September 17, 2014
Safety Profile of Intraoperative Corneal Debridement in Descemet Membrane Endothelial Keratoplasty (DMEK)-A
Sebastian Arens1, Stefan J Lang1,2, Daniel Böhringer1
1Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany, uni-freiburg.de.
Purpose:
To investigate the influence of intraoperative corneal debridement on postoperative outcomes in Descemet Membrane Endothelial Keratoplasty (DMEK).
Methods:
This retrospective comparative study analyzed 3168 eyes that underwent DMEK between 2012 and 2024. Intraoperative corneal debridement was performed in 215 eyes (6.8%) to improve visualization during the procedure. Survival time analyses with Kaplan-Meier curves and log-rank test and multifactorial Cox regression were conducted to assess the impact of corneal debridement on postoperative graft survival.
Results:
Bivariate survival analyses suggested that intraoperative corneal debridement during DMEK may be associated with worse postoperative outcomes in terms of visual acuity, endothelial cell density, graft survival, and perioperative complications. Using the log-rank test, significant differences were observed in endothelial cell density, postoperative regrafting, and visual acuity (p < 0.005), while the need for rebubbling was not statistically significant (p = 0.5). However, multifactorial Cox regression analysis, controlling for potential confounding factors, revealed that the difference in hazard ratios between the debridement and no-debridement groups had no statistically significant effect on graft survival (HR = 0.74, 95% CI: 0.49-1.11, p = 0.141). Patients with Fuchs' endothelial dystrophy had a significantly lower risk of graft failure compared to other indications (HR 0.41, p < 0.001).
Conclusions:
In bivariate analyses, intraoperative corneal debridement was associated with worse postoperative outcomes, including reduced visual acuity, endothelial cell density, and graft survival. However, these differences likely reflect the more severe cases in the debridement group. When adjusting for potential confounders, multifactorial Cox regression analysis showed that corneal debridement did not have a significant impact on graft survival. This suggests that while debridement may be associated with poorer outcomes in unadjusted analyses, it does not appear to adversely affect graft survival when accounting for other factors. Corneal debridement may therefore be a safe and viable option in DMEK, though further research is needed to confirm its impact on long-term outcomes.
